A carregar...
The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients
We demonstrate evidence supporting the efficacy of hydroxocobalamin in reducing vasopressor requirements for LVAD patients with refractory vasoplegia. Further study is needed to substantiate these findings and determine its optimal use in practice.
Na minha lista:
| Publicado no: | Clin Case Rep |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7495745/ https://ncbi.nlm.nih.gov/pubmed/32983485 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2967 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|